CS802086A2 - Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production - Google Patents
Method of substituted imidazopyrrole,-pyridine and-azepine derivatives productionInfo
- Publication number
- CS802086A2 CS802086A2 CS868020A CS802086A CS802086A2 CS 802086 A2 CS802086 A2 CS 802086A2 CS 868020 A CS868020 A CS 868020A CS 802086 A CS802086 A CS 802086A CS 802086 A2 CS802086 A2 CS 802086A2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- opt
- alkyl
- substd
- alkoxy
- etherified
- Prior art date
Links
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 1
- MHOZZUICEDXVGD-UHFFFAOYSA-N pyrrolo[2,3-d]imidazole Chemical class C1=NC2=CC=NC2=N1 MHOZZUICEDXVGD-UHFFFAOYSA-N 0.000 title 1
- -1 alkanoyl alkanoyloxy Chemical group 0.000 abstract 10
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 125000003545 alkoxy group Chemical group 0.000 abstract 6
- 229910052736 halogen Inorganic materials 0.000 abstract 6
- 150000002367 halogens Chemical class 0.000 abstract 6
- 125000001589 carboacyl group Chemical group 0.000 abstract 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 5
- 125000004423 acyloxy group Chemical group 0.000 abstract 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 4
- 125000004414 alkyl thio group Chemical group 0.000 abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 3
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 2
- 229910006069 SO3H Inorganic materials 0.000 abstract 2
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 abstract 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 2
- 125000004660 phenylalkylthio group Chemical group 0.000 abstract 2
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 2
- 102000014654 Aromatase Human genes 0.000 abstract 1
- 108010078554 Aromatase Proteins 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 125000005042 acyloxymethyl group Chemical group 0.000 abstract 1
- 125000004849 alkoxymethyl group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000005117 dialkylcarbamoyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 abstract 1
- 125000004970 halomethyl group Chemical group 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS868020A CS268686B2 (en) | 1985-06-18 | 1986-11-05 | Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS854449A CS268672B2 (en) | 1984-06-20 | 1985-06-18 | Method of substituted imidazo-(1,5-a)pyridine derivatives production |
| CS868020A CS268686B2 (en) | 1985-06-18 | 1986-11-05 | Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS802086A2 true CS802086A2 (en) | 1989-07-12 |
| CS268686B2 CS268686B2 (en) | 1990-04-11 |
Family
ID=5387250
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS868022A CS268688B2 (en) | 1985-06-18 | 1986-11-05 | Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production |
| CS868020A CS268686B2 (en) | 1985-06-18 | 1986-11-05 | Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS868022A CS268688B2 (en) | 1985-06-18 | 1986-11-05 | Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production |
Country Status (1)
| Country | Link |
|---|---|
| CS (2) | CS268688B2 (cs) |
-
1986
- 1986-11-05 CS CS868022A patent/CS268688B2/cs not_active IP Right Cessation
- 1986-11-05 CS CS868020A patent/CS268686B2/cs not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CS268686B2 (en) | 1990-04-11 |
| CS268688B2 (en) | 1990-04-11 |
| CS802286A2 (en) | 1989-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8802815L (sv) | Epipodofyllotoxin-glukosid-4'-fosfat-derivat | |
| Scheving et al. | Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation | |
| DK0585242T4 (da) | Sårheling | |
| EP0213776A3 (en) | Use of a cartilage-inducing factor (cif) for the manufacture of a medicament for treating inflammation | |
| TR200201052T2 (tr) | Yeni hücre farklılaştırıcı ajanlar sınıfı ve hıstone deacetylase inhibitörleri, ve burada kullanım yöntemleri | |
| Zhang | On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia | |
| Cassin et al. | The effects of bumetanide and furosemide on lung liquid secretion in fetal sheep | |
| Schneider et al. | Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey. | |
| IS1549B (is) | 1,4 - Dihydropyridines, og aðferð við framleiðsluþess svo og notkun þess í lækningaskyni | |
| NZ333063A (en) | Dibenzofuran sulfonamide derivatives as matrix metalloproteinase inhibitors | |
| CS801986A2 (en) | Method of substituted imidazopyrrole,-pyridine and-azepine derivatives production | |
| DE69807710D1 (de) | Verwendung von Latenz Assoziierten Peptiden in der Herstellung eines Medikaments zur Verbesserung der Wundheilung. | |
| PT1003534E (pt) | Reovirus para o tratamento de neoplasia | |
| NO880731L (no) | Fremgangsmaate for fremstilling av farmasoeytisk aktive naftalenderivater. | |
| DE69216013D1 (de) | Imidazoindolizinderivate mit Angiotensin-II Hemmwirkung | |
| FI953841A0 (fi) | Substituoituja kinoliinijohdannaisia, menetelmä niiden valmistamseksi | |
| DE69901506D1 (de) | Verwendung von natriumchlorid zur verminderung der gastrointestinalen toxizität von camptotecinderivaten. | |
| NO950360D0 (no) | Nytt legemiddel som inneholder 3-fenylsulfonyl-3,7-diazabisyklo[3,3,1Ånonan-forbindelser | |
| DK0533210T3 (da) | Protein C-holdige farmaceutiske præparater som midler mod inflammation. | |
| Livingston et al. | Sequential Combination Chemotherapy for Advanced, Recurrent, Squamous Carcinoma of the Head and | |
| Tomono et al. | Synergistic potentiating effects of choline phosphate and ethanolamine on insulin-induced DNA synthesis in NIH 3T3 fibroblasts | |
| AU3818989A (en) | The use of substituted 3,4-dihydro-2h-benzopyrans as remedies for constructive functional disorders of the lungs and/or disorders of the efferent urinary passages | |
| FR2307536A1 (fr) | Derives d'acide 5-sulfamoyl-anthranilique a substituants basiques et leur procede de preparation | |
| NO890531D0 (no) | 3,4-dihydro-2-alkyl-3-okso-n-aryl-2h-(1)benzotieno(3,2-e)-1,2-tiazin-4-karboksamid-1,1-dioksyder. | |
| Pecoits-Filho et al. | Roxadustat Treatment Results in Consistent Improvements in Hemoglobin (Hb) vs. Placebo: An Analysis of Three Multinational Randomized Clinical Trials in Patients with Non-Dialysis-Dependent CKD (NDD-CKD): TH-OR05 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4A | Patent expired |
Effective date: 20000618 |